These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 20553282)
21. Long stents as a risk factor for late stent thrombosis size does matter. Tommaso CL JACC Cardiovasc Interv; 2010 Apr; 3(4):390-1. PubMed ID: 20398865 [No Abstract] [Full Text] [Related]
22. Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction. Satler LF Catheter Cardiovasc Interv; 2011 Feb; 77(2):201. PubMed ID: 21290554 [No Abstract] [Full Text] [Related]
23. Treatment options for patients with left main coronary artery disease. Lee MS; Nguyen J Rev Cardiovasc Med; 2011; 12(2):e77-83. PubMed ID: 21796086 [TBL] [Abstract][Full Text] [Related]
24. Stent thrombosis with drug-eluting stents: a re-examination of the evidence. Kedia G; Lee MS Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249 [TBL] [Abstract][Full Text] [Related]
25. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy. Wykrzykowska JJ; Onuma Y; Serruys PW EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680 [No Abstract] [Full Text] [Related]
26. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best? Butman SM Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371 [No Abstract] [Full Text] [Related]
27. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297 [TBL] [Abstract][Full Text] [Related]
28. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582 [TBL] [Abstract][Full Text] [Related]
29. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849 [TBL] [Abstract][Full Text] [Related]
35. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903 [TBL] [Abstract][Full Text] [Related]
36. Oral sirolimus after bare metal stent implantation: a glimpse to the future. Mieres J Catheter Cardiovasc Interv; 2011 Jan; 77(1):158-9. PubMed ID: 20931667 [No Abstract] [Full Text] [Related]
37. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [TBL] [Abstract][Full Text] [Related]
39. Left main and high-risk PCI: what, exactly, is it high risk for? Safian RD Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347 [No Abstract] [Full Text] [Related]
40. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent. Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]